Untitled

Vision Research Reports shares the latest market insights, trends, and forecasts across industries like healthcare, technology, energy, and more helping businesses and readers stay ahead with data-driven research.

[apurvarahate]

North America Behavioural Health Market Size to Reach USD 63.81 Billion by 2035

Mental health has become a growing priority across North America, driving significant demand for behavioural health services and treatment solutions. According to recent market analysis, the North America Behavioural Health Market was valued at USD 48.41 billion in 2025, reached USD 49.77 billion in 2026, and is projected to grow to USD 63.81 billion by 2035, registering a CAGR of 2.80% from 2026 to 2035.

The North America behavioural health market size was evaluated at USD 48.41 billion in 2025 and is expected to grow around USD 63.81 billio

North America Behavioural Health Market Overview

Behavioural health services focus on diagnosing, treating, and managing mental health conditions, emotional disorders, and substance abuse issues. Growing public awareness, government support programs, insurance coverage expansion, and technological innovations are transforming the delivery of mental healthcare across the region.

The adoption of telehealth services, AI-powered diagnostics, mobile mental health applications, remote monitoring tools, and personalized treatment approaches is improving patient engagement and treatment outcomes.

Key Market Growth Drivers

Rising prevalence of mental health disorders

Increasing awareness and reduced stigma around mental healthcare

Expansion of telehealth and virtual counseling services

Growing adoption of digital therapy platforms

Government initiatives supporting mental health programs

Improved insurance coverage for behavioural health treatments

Advancements in AI-based diagnosis and remote patient monitoring

Technology Transforming Behavioural Healthcare

The behavioural health sector is rapidly embracing innovative technologies that improve diagnosis, treatment delivery, and patient engagement, including:

AI-powered mental health assessment tools

Mobile mental health applications

Cloud-based healthcare management systems

Telepsychiatry and virtual counseling

Remote patient monitoring platforms

Personalized treatment planning technologies

These innovations are helping healthcare providers improve treatment efficiency while expanding access to care for underserved populations.

Leading Companies in the Market

Major organizations operating in the North America Behavioural Health Market include:

Acadia Healthcare Company, Inc.

Universal Health Services, Inc. (UHS)

Behavioral Health Network, Inc.

CareTech Holdings PLC

Pyramid Healthcare, Inc.

Promises Behavioral Health, LLC

Magellan Health, Inc.

Sevita (formerly The MENTOR Network)

Rogers Behavioral Health

Ocean Healthcare

Ascension Behavioral Health

North Range Behavioral Health

Strategic Behavioral Health, LLC

Aurora Behavioral Health System

Haven Behavioral Healthcare, Inc.

Future Outlook

As mental health continues to gain greater recognition as a critical component of overall wellness, demand for behavioural health services is expected to rise steadily across North America. Expanding access to care, increasing digital health adoption, and growing investment in innovative treatment solutions will continue to shape the market's future.

With healthcare providers, governments, and technology companies working together to improve mental healthcare accessibility and outcomes, the North America Behavioural Health Market is well-positioned for sustained growth through 2035.

[apurvarahate]

North America Cancer Supportive Care Drugs Market Size to Reach USD 9.53 Billion by 2035

The North America cancer supportive care drugs market continues to play a vital role in improving the quality of life for cancer patients by helping manage treatment-related side effects such as anemia, nausea, pain, and infections. According to recent market analysis, the market was valued at USD 7.82 billion in 2025, reached USD 7.98 billion in 2026, and is projected to grow to USD 9.53 billion by 2035, expanding at a CAGR of 2% from 2026 to 2035.

The North America cancer supportive care drugs market size surpassed USD 7.82 billion in 2025 and is predicted to reach around USD 9.53 bill

North America Cancer Supportive Care Drugs Market Overview

Cancer supportive care drugs are essential components of oncology treatment plans, helping patients better tolerate therapies such as chemotherapy, radiation therapy, and targeted treatments. The increasing prevalence of cancer across North America, combined with growing awareness of supportive care benefits, is driving demand for these medications.

Healthcare providers are increasingly integrating supportive care into standard oncology protocols to improve treatment outcomes, reduce complications, and enhance patient comfort throughout the treatment journey.

Key Market Growth Drivers

Rising incidence of cancer across North America

Growing adoption of advanced supportive care therapies

Increased focus on patient-centered cancer treatment

Strong healthcare infrastructure and access to treatment

Continuous advancements in supportive care drug development

Greater awareness of managing chemotherapy-related side effects

Competitive Landscape

Several leading pharmaceutical companies are actively contributing to the growth and innovation of the North America Cancer Supportive Care Drugs Market, including:

Merck & Co.

Novartis AG

F. Hoffmann-La Roche AG

Johnson & Johnson

GlaxoSmithKline Plc

Helsinn Healthcare SA

Baxter International Inc.

Future Outlook

As cancer incidence continues to rise and healthcare systems prioritize comprehensive patient care, supportive care drugs will remain a critical component of oncology treatment. Advances in targeted supportive therapies, improved patient management strategies, and increasing integration of supportive care into treatment protocols are expected to sustain market growth through 2035.

The North America Cancer Supportive Care Drugs Market is positioned for steady expansion, supporting better patient outcomes and enhancing the overall cancer treatment experience.

[apurvarahate]

📊 Autoimmune Disease Diagnosis Market on the Rise

The global Autoimmune Disease Diagnosis Market was valued at USD 6.30B in 2025 and is projected to reach USD 13.74B by 2035, expanding at a CAGR of 8.11% from 2026–2035. 🚀

🔬 Growth is fueled by the rising prevalence of autoimmune disorders such as rheumatoid arthritis, lupus, and thyroiditis, along with increasing adoption of advanced diagnostic technologies including automated immunoassays, multiplex testing, and ELISA platforms.

The autoimmune disease diagnosis market size was reached at USD 6.30 Bn in 2025 and is expected to be worth around USD 13.74 Bn by 2035 with

🧪 Consumables & assay kits dominate the market due to the high demand for specialized testing reagents, while routine laboratory tests are expected to witness strong growth because of their cost-effective and high-volume usage.

🏥 Hospitals currently hold the largest share owing to advanced diagnostic infrastructure, while clinical laboratories are emerging as the fastest-growing end users due to automation and high-throughput diagnostic capabilities.

🌍 Leading companies shaping the market include Thermo Fisher Scientific, Siemens Healthineers, Abbott Laboratories, and Bio-Rad Laboratories.

[apurvarahate]

🔬 In Vitro Diagnostics Contract Manufacturing Market to Reach $69.39B by 2035

The global IVD contract manufacturing market was valued at $25.71B in 2025 and is projected to reach $69.39B by 2035, growing at a 10.44% CAGR.

The in vitro diagnostics contract manufacturing market size was evaluated at USD 25.71 Bn in 2025 and is anticipated to reach around USD 69.

📈 Key Growth Drivers

• Rising demand for diagnostic testing • Increasing outsourcing by diagnostic companies • Growth in molecular diagnostics & point-of-care testing • Expansion of personalized medicine

🧪 Key Insights

• North America held the largest share (43%) in 2025 • Asia-Pacific expected to grow fastest • Reagents & consumables dominated with ~70% revenue share • Immunoassays lead among technologies

🤖 AI Impact:

AI-powered data analysis and workflow automation are enhancing diagnostic accuracy, improving manufacturing efficiency, and supporting personalized healthcare.

With rising chronic diseases, rapid testing demand, and expanding biotech innovation, the IVD contract manufacturing industry is set for strong long-term growth.

[apurvarahate]

🧬 Sequencing Reagents Market to Witness Rapid Growth by 2035

The global Sequencing Reagents Market was valued at USD 10.32 billion in 2025 and is projected to reach USD 51.61 billion by 2035, expanding at a remarkable CAGR of 17.46% (2026–2035). 📈

The global sequencing reagents market size was evaluated at USD 10.32 Bn in 2025 and is anticipated to reach around USD 51.61 Bn by 2035, g

🔬 Market Highlights

• NGS technology dominated the market with 90% share in 2025 • Third-generation sequencing expected to grow at 21.1% CAGR • Sequencing kits led the product segment with 36% share • Library preparation kits projected to grow rapidly at 18.8% CAGR

📌 Applications Driving Growth

• Oncology diagnostics and tumor profiling • Infectious disease detection and surveillance • Consumer genomics and ancestry testing • Agrigenomics and microbiome research

Regional Insights

• North America held the largest share at 50% in 2025 due to strong genomics infrastructure and research funding. • Asia-Pacific is expected to record the fastest growth (19.2% CAGR) driven by expanding biotechnology sectors in China, India, and Japan.

[apurvarahate]

Autoimmune Disease Diagnosis Market Insights (2026–2035)

The global Autoimmune Disease Diagnosis Market was valued at USD 6.30 billion in 2025 and is projected to reach USD 13.74 billion by 2035, expanding at a CAGR of 8.11%. The growth is fueled by the rising prevalence of autoimmune disorders, rapid advancements in diagnostic technologies, and increasing awareness of early disease detection.

The autoimmune disease diagnosis market size was reached at USD 6.30 Bn in 2025 and is expected to be worth around USD 13.74 Bn by 2035 with

🔬 Key Market Highlights:

• Consumables & Assay Kits dominate the market due to the growing demand for specialized diagnostic assays for conditions like lupus and rheumatoid arthritis. • Autoantibody & Immunologic Tests lead the testing segment as essential tools for early identification of immune markers before symptoms appear. • Routine Laboratory Tests are expected to witness strong growth with increasing adoption of automated diagnostic platforms. • Systemic Autoimmune Diseases hold the largest share due to the need for multi-organ testing and complex diagnostic procedures. • Clinical Laboratories are projected to grow rapidly with the rise of high-throughput automation and outsourced diagnostic services.

🏢 Key Industry Players

Thermo Fisher Scientific | Siemens Healthineers | Abbott | Bio-Rad Laboratories | F. Hoffmann-La Roche

[apurvarahate]

🔬 Biotechnology & Pharmaceutical Services Outsourcing Market to Reach USD 87.55 Billion by 2035

The biotechnology and pharmaceutical services outsourcing market is rapidly transforming into a strategic pillar of global drug development. Valued at USD 50.96 billion in 2025, the market is projected to reach USD 87.55 billion by 2035, expanding at a CAGR of 5.56% (2026–2035).

The biotechnology and pharmaceutical services outsourcing market size was evaluated at USD 50.96 Bn in 2025 and is projected to hit around U

As R&D complexity rises and regulatory frameworks tighten, pharma and biotech companies are increasingly relying on outsourcing partners to accelerate innovation, manage compliance, and optimize costs.

📊 Market Snapshot

2025 Market Size: USD 50.96 Billion

2035 Forecast: USD 87.55 Billion

Growth Rate: 5.56% CAGR

Fastest Growing Region: Asia Pacific

Leading End-User: Pharmaceutical Companies (60% share in 2025)

🚀 Why Outsourcing Is Accelerating

✔ Rising R&D expenditure and need for operational efficiency ✔ Increasing complexity in biologics, gene therapy & precision medicine ✔ Growing demand for regulatory expertise ✔ Expansion of decentralized clinical trials ✔ Adoption of AI, big data & digital trial platforms

[apurvarahate]

U.S. Wound Irrigation Systems Market to Reach USD 170.1M by 2035 | CAGR 4.07%

The U.S. wound irrigation systems market was valued at USD 114.1M in 2025 and is projected to grow steadily through 2035, driven by rising chronic wounds, infection control focus, and expanding surgical volumes.

The U.S. wound irrigation systems market size was exhibited at USD 114.1 Mn in 2025 and is projected to hit around USD 170.1 Mn by 2035, gro

📊 Key Highlights:

• Manual systems led with 55% revenue share (2025) • Battery-operated devices fastest growing (CAGR 4.1%) • Chronic wounds accounted for 33.7% share • Hospitals dominated with 40% market share • Wound care centers growing at 4.2% CAGR

🔎 Growth Drivers:

✔ Rising diabetic foot ulcers & pressure injuries ✔ Increasing surgical procedures ✔ Strong infection prevention protocols ✔ Expansion of outpatient & home-based wound care

⚡ Emerging Trends:

• Shift toward battery-powered precision systems • Disposable, single-use components • Biofilm-targeted irrigation solutions • AI-powered wound assessment & remote monitoring

Major players include BD, Stryker, Zimmer Biomet, Medline Industries, Essity Health & Medical, and WestMed Products.T

[apurvarahate]

Portable Ultrasound Devices Market to Reach USD 8.98 Billion by 2035

The market was valued at USD 6.08B in 2025 and is projected to grow at a 3.98% CAGR (2026–2035), driven by rising demand for point-of-care diagnostics, AI integration, and decentralized healthcare.

The portable ultrasound devices market size was exhibited at USD 6.08 Bn in 2025 and is projected to hit around USD 8.98 Bn by 2035, growing

🔹 Cart/Trolley systems led with 65.9% share 🔹 Handheld devices = fastest-growing segment 🔹 OB/GYN dominated (46.6% share) 🔹 Doppler tech held 46.8% revenue share 🔹 Hospitals led end-use (54%+) 🔹 North America accounted for 38% market share

AI-powered imaging, wireless probes, tele-ultrasound & home healthcare adoption are reshaping diagnostic imaging globally.

[apurvarahate]

U.S. Automated and Closed Cell Therapy Processing Systems Market (2026–2035)

The U.S. automated and closed cell therapy processing systems market is set for strong expansion, growing from USD 778.8 million in 2025 to USD 4,404.72 million by 2035, at a CAGR of 18.92%.

The U.S. automated and closed cell therapy processing systems market size was exhibited at USD 778.8 Mn in 2025 and is projected to hit arou

🔬 Why Automation Matters

Automated and closed systems:

Reduce contamination risks

Minimize manual errors

Ensure regulatory compliance

Enable scalable production

With 1,000+ cell and gene therapy candidates under development in the U.S., demand for advanced bioprocessing platforms continues to rise.

Key Highlights

Separation workflow led the market (31.10% share in 2025)

Non-stem cell therapy systems dominated by type (61.84%)

Pre-commercial/R&D scale systems held 75% market share

Commercial-scale systems expected to grow rapidly

[apurvarahate]

Spine Biologics Market Outlook 2026–2035

The Spine Biologics Market was valued at USD 3.49 billion in 2025 and is projected to reach USD 5.20 billion by 2035, growing at a CAGR of 4.07%.

The spine biologics market size was exhibited at USD 3.35 billion in 2024 and is projected to hit around USD 5.01 billion by 2034, growing a

Key Highlights

Spinal allografts dominated with 59% share in 2025

Cell-based matrices are the fastest-growing segment (7.0% CAGR)

ACDF surgeries led the market (25.9% share)

North America held 49% of global revenue

📈 What’s Driving Growth?

Rising cases of degenerative disc disease & spinal disorders

Growing adoption of minimally invasive spine surgeries

Advancements in regenerative medicine & stem cell therapies

[apurvarahate]

📱🌸 Women’s Health App Market Set for Remarkable Growth Through 2035

The global Women’s Health App Market was valued at USD 5.83B in 2025 and is projected to reach USD 28.91B by 2035, expanding at a strong CAGR of 17.36% (2026–2035).

Key Highlights:

• Menstrual Health led with 37.68% revenue share in 2025 • Smartphones dominated with 69% share • North America accounted for 38% of total revenue • Asia Pacific expected to grow at the fastest CAGR

Major Growth Drivers:

• Rising awareness of preventive & reproductive health • AI-powered personalized insights & predictive analytics • Expansion of telehealth & wearable integration • Growing focus on menopause & midlife health management

💡 Industry Momentum: Recent launches like Sidekick Health’s MENO! App and AI-powered platforms such as LAIQA reflect rising innovation in femtech. Increased VC funding and employer-backed women’s health benefits are further accelerating adoption.

[apurvarahate]

Thyroid Gland Disorder Treatment Market – Global Outlook 2026–2035

The global market size was valued at USD 2.47 Billion in 2025 and is projected to reach USD 3.54 Billion by 2035, growing at a CAGR of 3.66%.

The thyroid gland disorder treatment market size was evaluated at USD 2.47 Bn in 2025 and is projected to hit around USD 3.54 Bn by 2035, gr

Key Insights:

• Hypothyroidism led with 68.7% share (2025) • Levothyroxine accounted for 50.5% revenue share • Oral therapies dominated with 58% share • Wholesale distribution held 46.7% share • North America captured 35%+ market revenue

[apurvarahate]

🚑 Ambulance Equipment Market Set for Steady Growth Through 2035

The global Ambulance Equipment Market was valued at USD 5.56 Billion in 2025 and is projected to reach USD 8.12 Billion by 2035, growing at a CAGR of 3.86% (2026–2035).

The ambulance equipment market size was exhibited at USD 5.56 Bn in 2025 and is projected to hit around USD 7.84 Bn by 2035, growing at a CA

📊 Market Snapshot

• 2026 Market Size: USD 5.78 Billion • 2035 Projection: USD 8.12 Billion • CAGR: 3.86% • North America Share (2025): 30%

🔎 Key Takeaways

✔ Transportation equipment dominated with 21.3% share (2025) ✔ Ground ambulances led with 46% revenue share ✔ Burn care equipment fastest-growing (4.7% CAGR) ✔ Air ambulance segment growing at 4.1% CAGR

[apurvarahate]

Hyperbaric Oxygen Therapy Devices Market Set for Steady Growth Through 2035

The global HBOT devices market was valued at USD 3.41B in 2025 and is projected to reach USD 5.53B by 2035, growing at a 4.95% CAGR.

The hyperbaric oxygen therapy devices market size was exhibited at USD 3.41 Bn in 2025 and is projected to hit around USD 5.53 Bn by 2035, g

Growth Drivers:

✔ Rising chronic wound & diabetic foot ulcer cases ✔ Expanding neurological rehabilitation research ✔ Growing adoption in trauma & infection treatment ✔ Increasing healthcare investments in Asia Pacific

[apurvarahate]

Healthcare Digital Twins Market Set for 24%+ CAGR Growth Through 2035

The global Healthcare Digital Twins Market was valued at USD 1,129.43 Mn in 2025 and is projected to reach USD 9,956.34 Mn by 2035, expanding at a robust CAGR of 24.32% (2026–2035).

The healthcare digital twins market size was evaluated at USD 1,129.43 Mn in 2025 and is projected to hit around USD 9,956.34 Mn by 2035, gr

📊 Key Highlights:

• Software segment dominated with 78.8% share (2025) • Personalized medicine led applications with 27.4% share • Providers accounted for 37% revenue share • North America held 47% market share

🚀 What’s Driving Growth?

✔ Rapid healthcare digitalization ✔ Rising demand for personalized & predictive care ✔ AI, IoT & cloud-powered real-time simulation ✔ Growing adoption in drug discovery & clinical trial modeling ✔ Expansion in telemedicine & remote monitoring

[apurvarahate]

🌿 Morocco Medical Cannabis Market Set for Exponential Growth Through 2035

The Morocco medical cannabis market was valued at USD 157.4 million in 2025 and is anticipated to reach approximately USD 4,850.35 million by 2035, expanding at a robust CAGR of 40.89% over the forecast period from 2026 to 2035.

The Morocco medical cannabis market size was exhibited at USD 157.4 Mn in 2025 and is projected to hit around USD 4,850.35 Mn by 2035, growi

🚀 Key Growth Drivers • Structured legalization framework • Rising global demand for CBD & THC products • EU import dependency • Rural economic reform initiatives • Growing clinical acceptance of cannabinoid therapies

⚠️ Challenges

• Limited domestic medical infrastructure • Healthcare professional training gaps • Social stigma around cannabis use • Early-stage pharmaceutical integration